The usefulness of (1,3)-ß-d-glucan (BDG) detection for the diagnosis of intra-abdominal candidiasis and treatment monitoring is unknown. A prospective, single-center study of consecutive patients admitted to an ICU with complicated intra-abdominal infection (IAI) over a 2-year period was conducted. BDG was measured in the peritoneal fluid and serum between day 1 (D1) and D10. Patients with a positive peritoneal fluid yeast culture (YP) were compared to those with a negative yeast culture (YN). The evolution of serum BDG was compared in the two groups. Seventy patients were included (sixty-five analyzed): YP group (n = 19) and YN group (n = 46). Median peritoneal BDG concentration during surgery was 2890 pg.mL [IQR: 942-12,326] in the YP group vs. 1202 pg.mL [IQR: 317-4223] in the YN group ( = 0.13). Initial serum BDG concentration was 130 pg.mL [IQR: 55-259] in the YP group vs. 88 pg.mL [IQR: 44-296] in the YN group ( = 0.78). No difference in evolution of serum BDG concentrations was observed between the groups ( = 0.18). In conclusion, neither peritoneal BDG nor serum BDG appear to be good discriminating markers for the diagnosis of yeast IAI. In addition, monitoring the evolution of serum BDG in yeast IAI did not appear to be of any diagnostic value.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143807 | PMC |
| http://dx.doi.org/10.3390/jof8050487 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Evaluation of a newer (1, 3)-β-D-glucan chemiluminescent immunoassay for invasive candidiasis: A study from a tertiary care center.
Curr Med Mycol
May 2024
Department of Microbiology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi-110029, India.
Article Synopsis
- Invasive candidiasis (IC) is a major concern in hospitals, often difficult to diagnose due to limitations in blood culture methods.
- A study evaluated the effectiveness of the FungiXpert® BDG Detection Kit for diagnosing IC, showing it had a sensitivity of 60.52% and specificity of 81.81% among 80 patients tested.
- Results indicated that higher BDG levels correlated with more severe outcomes, suggesting the kit could be useful for diagnosis, especially in resource-limited settings.
Fungal biomarkers in HIV-associated disseminated histoplasmosis: a multicenter diagnostic accuracy study on the Guiana shield.
Int J Infect Dis
December 2024
Centre d'Investigation Clinique Antilles Guyane Inserm CIC1424, Centre Hospitalier de Cayenne, Cayenne, French Guiana; DFR Santé, Université de Guyane, Cayenne, French Guiana; CRB Amazonie, Centre Hospitalier de Cayenne, Cayenne, French Guiana.
Objectives: Diagnosis of HIV-associated histoplasmosis remains challenging. Our objective was to compare the performances of (1→3)-β-D-Glucan (BDG) and aspergillus galactomannan (GM) antigen for the diagnosis of HIV-associated histoplasmosis.
Methods: We performed a diagnostic accuracy study using frozen primary serum specimens issued from consecutive hospitalized people living with HIV (PLWH) and blindly tested for BDG and GM using Fungitell and PlateliaAspergillus, respectively.
Identification and quantification of the molecular species of bilirubin BDG, BMG and UCB by LC‒MS/MS in hyperbilirubinemic human serum.
PLoS One
November 2024
Liver Research Unit, Medica Sur Clinic & Foundation, Mexico City, Mexico.
Background And Aims: Unconjugated bilirubin (UCB) is a byproduct of the heme group that indicates irregularities in the metabolism of several important biological molecules, such as hemoglobin. UCB is processed by hepatic UGT1A1, which catalyzes its conjugation to the metabolites bilirubin diglucuronide (BDG) and bilirubin monoglucuronide (BMG). The serum concentrations of BDG and BMG may indicate liver injury or dysfunction.
View Article and Find Full Text PDFDiagnostic test accuracy of the Fungitell serum (1→3)-β-D-glucan assay for the diagnosis of Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis.
Clin Microbiol Infect
November 2024
Division of Experimental Medicine, Department of Medicine, McGill University, Montréal, Quebec, Canada; Clinical Practice Assessment Unit, Department of Medicine, McGill University Health Centre, Montréal, Quebec, Canada; Division of Infectious Diseases, Department of Medicine, McGill University Health Centre, Quebec, Montréal, Canada.
Article Synopsis
- The diagnosis of Pneumocystis jirovecii pneumonia (PCP) is complicated due to the limitations of current diagnostic tests and the under-validated cut-off of 80pg/mL for the Fungitell BDG serum assay.
- A systematic review and meta-analysis examined the effectiveness of the Fungitell BDG assay, involving 26 studies and over 5,000 patients to assess its diagnostic accuracy for PCP.
- The findings suggest using a cut-off of <80pg/mL as a strong negative indicator for PCP, while >400pg/mL can provide a reliable indication of the disease, although sensitivity decreases at higher cut-off levels.
Background: Sarcoidosis is a multi-system disease frequently affecting the lungs. It is thought to be mediated by gene-environment interaction; for example, epidemiological data show organic aerosol exposure increases risk of pulmonary sarcoidosis.
Research Question: Does exposure to bioaerosol associate with worse lung disease in patients with pulmonary sarcoidosis?
Research Question: Using an observational, cohort study design, we measured residential exposure to fungal and bacterial cell wall material, β-(1,3)-D-glucan (BDG) and endotoxin, respectively, in healthy control subjects and those with pulmonary sarcoidosis.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!